Year II · No. 665 · 1,823 entries Tuesday, October 27, 2026 ES EN Get the weekly digest

US · 16 entries · 1 publication

AIM

AIM ImmunoTech Inc.

Entries
16
Bullish
4
Bearish
0
First
Oct 3, 2025
Latest
Mar 2, 2026

▲ 4 bullish ▼ 0 bearish · 12 no stance

More bullish than bearish among those that state a stance.

Jan 25 – Oct 26 · per month

Full performance tracking Pro · free during launch

Alpha of every thesis on AIM at 1, 3 and 6 months and since publication, and the full chart vs its benchmark.

Free during launch: log in or sign up with your email to see it.

Sign up free

Timeline

Newest to oldest
  1. March 2026 1 entry

    Substack · Increasing Odds · Saesch

    AIM A-Z Part 37: Quality Distributor

    Ticker 601 to 612 on London's Alternative Investment Market (AIM)

    AIM1,178 words

    Since publication −79.2% α −90.8 pp vs S&P 500 · USD

  2. February 2026 2 entries

    Substack · Increasing Odds · Saesch

    AIM A-Z Part 35: Family Business

    Ticker 573 to 585 on London's Alternative Investment Market (AIM)

    AIM1,550 words

    Since publication −85.2% α −97.5 pp vs S&P 500 · USD

  3. January 2026 4 entries

    Substack · Increasing Odds · Saesch

    AIM A-Z Part 34: Retail, Gold, Whiskey

    Ticker 561 to 572 on London's Alternative Investment Market (AIM)

    AIM1,431 words

    Since publication −85.7% α −96.3 pp vs S&P 500 · USD

    Substack · Increasing Odds · Saesch

    AIM A-Z Part 32: Cheap Serial Acquirer

    Ticker 536 to 550 on London's Alternative Investment Market (AIM)

    BullishAIM1,472 words

    Since publication −87.7% α −98.3 pp vs S&P 500 · USD

    Substack · Increasing Odds · Saesch

    AIM A-Z Part 31: Niche Businesses

    Ticker 521 to 535 on London's Alternative Investment Market (AIM)

    AIM1,327 words

    Since publication −87.2% α −97.4 pp vs S&P 500 · USD

  4. December 2025 2 entries
  5. November 2025 4 entries
  6. October 2025 3 entries

Prices as of the Oct 27, 2026 close. Past performance does not guarantee future results. Price-only, excluding dividends, in local currency. Data may be delayed or inaccurate. Not investment advice. How it is calculated.